Commonly reported side effects of blinatumomab include: convulsions, encephalopathy, febrile neutropenia, opportunistic infection, cytokine release syndrome, confusion, disorientation, equilibrium disturbance, fever, headache, hypotension, impaired consciousness, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, nausea, neutropenia, speech disturbance, and bacteremia. Other side effects include: pneumonia, sepsis, tumor lysis syndrome, and increased serum bilirubin.  See below for a comprehensive list of adverse effects.
Applies to blinatumomab: intravenous powder for solution
In addition to its needed effects, some unwanted effects may be caused by blinatumomab. In the event that any of these side effects do occur, they may require medical attention.

If any of the following side effects occur while taking blinatumomab, check with your doctor or nurse immediately:
Some of the side effects that can occur with blinatumomab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to blinatumomab: intravenous powder for injection
Very common (10% or more): Hypotension (up to 11%)Common (1% to 10%): Hypertension, tachycardia[Ref]
Very common (10% or more): Rash (e.g., erythema, rash, erythematous rash, generalized rash, macular rash, maculopapular rash, papular rash, vesicular rash)[Ref]
Very common (10% or more): Nausea (up to 25%), constipation (up to 20%), diarrhea (e.g., colitis, diarrhea, enteritis, and neutropenic colitis) (up to 20%), abdominal pain (up to 15%), vomiting (up to 13%)[Ref]
Very common (10% or more): Febrile neutropenia (up to 25%), anemia (up to 18%), neutropenia (up to 16%), thrombocytopenia (up to 11%)Common (1% to 10%): Leukopenia, leukocytosis, lymphopeniaUncommon (0.1% to 1%): Capillary leak syndrome[Ref]
Common (1% to 10%): Hypersensitivity[Ref]
Very common (10% or more): Cytokine release syndrome (up to 11%), various pathogen infections (44%), bacterial infections (19%), fungal infections (15%), viral infections (13%), increased weight (up to 11%)Common (1% to 10%): Pneumonia, sepsis, decreased immunoglobulins, increased blood bilirubin, increased gammaglutamyl-transferase, increased liver enzymes[Ref]
Common (1% to 10%): Cytokine storm[Ref]
Very common (10% or more): Hypokalemia (up to 23%), hypomagnesemia (up to 12%), hyperglycemia (up to 11%), decreased appetite (up to 10%)Common (1% to 10%): Hypophosphatemia, tumor lysis syndrome, hypoalbuminemia[Ref]
Very common (10% or more): Back pain (14%), pain in extremity (up to 12%), bone pain (11%), arthralgia (10%)[Ref]
Very common (10% or more): Headache (up to 36%), tremor (e.g., resting tremor and tremor) (up to 20%), dizziness (up to 14%)Common (1% to 10%): Encephalopathy, paresthesia, aphasia, convulsion, memory impairment, cognitive disorderUncommon (0.1% to 1%): Speech disorder[Ref]
Very common (10% or more): Pyrexia (up to 62%), peripheral edema (up to 25%), fatigue (up to 17%), chills (up to 15%), chest pain (up to 11%)INVESTIGATIONS:Very common (10% or more): Increased alanine aminotransferase (up to 12%), increased aspartate aminotransferase (up to 11%)[Ref]
Very common (10% or more): Insomnia (up to 15%),Common (1% to 10%): Confusion, disorientation[Ref]
Very common (10% or more): Cough (up to 19%), dyspnea (e.g., acute respiratory failure, bronchial hyperactivity, bronchospasm, dyspnea, dyspnea exertional, respiratory distress, respiratory failure, wheezing) (up to 15%)Uncommon (0.1% to 1%): Bronchospasm[Ref]
1. "Product Information. Blincyto (blinatumomab)." Amgen USA, Thousand Oaks, CA. 
2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
Not all side effects for blinatumomab may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Agitation
bloating or swelling of the face, arms, hands, lower legs, or feet
blurred vision
chest pain
confusion
cough or hoarseness
dizziness
fever or chills
hallucinations
headache
irritability
lower back or side pain
painful or difficult urination
pale skin
pinpoint red spots on the skin
seizures
sore throat
stiff neck
tightness in the chest
tingling of the hands or feet
troubled breathing
unusual bleeding or bruising
unusual tiredness or weakness
unusual weight gain or loss
vomiting


Cloudy urine
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
lack or loss of strength
persistent bleeding or oozing from puncture sites, mouth, or nose
rash
stomach pain
sweating
swelling of the hands, ankles, feet, or lower legs
ulcers, sores, or white spots in the mouth


Bone, joint, or muscle pain
change in urination
decreased appetite
diarrhea
difficulty having a bowel movement (stool)
dry mouth
increased hunger or thirst
irregular heartbeat
muscle pain or cramps
pain in the arms or legs
shakiness in the legs, arms, hands, or feet

